Antibody reactivity against TKTL1 was assessed as above, on the same 3 normal mammary glands and 3 simple tubulo-papillary carcinomas (1 well-differentiated and 2 moderately differentiated) by Western immunoblotting. This evidence concerns the gene TKTL1 and thyroid gland papillary carcinoma.